Concentrix Corporation (NASDAQ:CNXC) Given Average Recommendation of “Hold” by Brokerages

Shares of Concentrix Corporation (NASDAQ:CNXCGet Free Report) have earned a consensus recommendation of “Hold” from the six analysts that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, one has given a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $32.75.

Several equities research analysts have recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Robert W. Baird dropped their target price on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a report on Tuesday, June 30th. Zacks Research cut Concentrix from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 2nd. Wall Street Zen downgraded Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Finally, Bank of America lowered their price objective on Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research report on Tuesday, June 30th.

Get Our Latest Stock Analysis on CNXC

Insiders Place Their Bets

In related news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total value of $133,500,000.00. Following the completion of the transaction, the insider directly owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. This represents a 68.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.90% of the stock is currently owned by insiders.

Institutional Trading of Concentrix

Several institutional investors have recently modified their holdings of the stock. Geneos Wealth Management Inc. lifted its position in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares during the last quarter. Larson Financial Group LLC grew its position in shares of Concentrix by 224.9% in the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after buying an additional 479 shares during the last quarter. Allworth Financial LP raised its stake in Concentrix by 90.6% during the 3rd quarter. Allworth Financial LP now owns 856 shares of the company’s stock worth $40,000 after acquiring an additional 407 shares in the last quarter. Global Retirement Partners LLC raised its stake in Concentrix by 1,032.5% during the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after acquiring an additional 795 shares in the last quarter. Finally, Rothschild Investment LLC lifted its position in Concentrix by 52.0% in the fourth quarter. Rothschild Investment LLC now owns 1,146 shares of the company’s stock valued at $48,000 after acquiring an additional 392 shares during the last quarter. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Stock Performance

Shares of Concentrix stock opened at $22.25 on Friday. The business has a 50-day simple moving average of $25.04 and a 200-day simple moving average of $29.84. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. Concentrix has a one year low of $19.12 and a one year high of $60.96. The company has a market cap of $1.36 billion, a PE ratio of -1.04, a P/E/G ratio of 0.41 and a beta of 0.47.

Concentrix (NASDAQ:CNXCGet Free Report) last issued its earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing the consensus estimate of $2.64 by ($0.01). Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. During the same period last year, the business earned $2.70 EPS. The firm’s revenue was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, equities research analysts forecast that Concentrix will post 9.67 EPS for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Investors of record on Friday, July 24th will be paid a dividend of $0.36 per share. The ex-dividend date is Friday, July 24th. This represents a $1.44 annualized dividend and a yield of 6.5%. Concentrix’s payout ratio is presently -6.75%.

About Concentrix

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Further Reading

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.